News
Home » News
Response Criteria and PRRT Treatment
Through her 2021 NETRF Investigator Award, Lisa Bodei, MD, PhD, professor of radiology at Weill Cornell Medical College, attending physician and director of targeted radionuclide
Rep. Joaquin Castro Shares his Personal NET Story at NETRF Patient Conference
United States Congressman Joaquin Castro (TX) joined the NET community in Austin, Texas on September 23rd and shared, for the first time publicly, his personal
Dr. Iacovos Michael Receives NETRF/NANETS Award
NETRF, in partnership with the North American Neuroendocrine Tumor Society (NANETS), is pleased to announce that Iacovos Michael, PhD, Scientist at Sunnybrook Research Institute and
Cookies for Cancer
In December 2022, four neighborhood girls from Libertyville, Il, gathered to support cancer research for the Neuroendocrine Tumor Research Foundation with a “Cookies for Cancer”
ENETS Meeting Showcases NETRF-funded Basic and Translational Research
NETRF’s impact on neuroendocrine cancer research was evident at the 20th Annual European Neuroendocrine Tumor Society (ENETS) Conference, held March 22-24 in Vienna. The ENETS
Ancora: An Easier Way to Find a Clinical Trial
A key tenet of NETRF’s mission is to help NET patients navigate the challenges of living with NET cancer. Participating in a clinical trial can
Meet Brittany Holzhauer: NET patient & co-founder of The CureNET Project
We are very grateful to Buckeye Cable Arts Network for allowing us to promote and share this wonderful story reporter Fayth Atkins produced about NET
Be Heard: Share your experience with Carcinoid Syndrome with the FDA
BE HEARD: Share your story with staff of the FDA about your experience or your loved one’s living with #CarcinoidSyndrome (CS). #FDA’s Patient Affairs and NORD are hosting
Out of an enemy, came a calling
NET patient, oncologist, and NETRF Board Member Mark Lewis, MD, is a native Scotsman who moved to Austin, TX as a young man when his
“Collaborative oncology” necessary for Cancer Moonshot success
The Cancer Moonshot’s success relies on ‘collaborative oncology.’ Just last month, the Neuroendocrine Tumor Research Foundation (NETRF) hosted our first in-person/hybrid research symposium since going